Berenberg Bank restated their buy rating on shares of CVS Group (LON:CVSG – Free Report) in a research report report published on Tuesday morning, Marketbeat reports. They currently have a GBX 2,000 price objective on the stock.
CVSG has been the topic of a number of other research reports. Peel Hunt reiterated a “buy” rating and set a GBX 1,600 price target on shares of CVS Group in a report on Tuesday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the stock a “buy” rating in a report on Tuesday, October 21st. Royal Bank Of Canada increased their target price on CVS Group from GBX 1,500 to GBX 1,900 and gave the company an “outperform” rating in a research note on Tuesday, October 21st. Finally, Jefferies Financial Group lifted their target price on CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,724.
Get Our Latest Research Report on CVS Group
CVS Group Price Performance
CVS Group (LON:CVSG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 7th. The company reported GBX 80.10 earnings per share (EPS) for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. As a group, equities analysts expect that CVS Group will post 93.9393939 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Robin Alfonso bought 870 shares of the business’s stock in a transaction on Monday, November 17th. The stock was acquired at an average price of GBX 1,147 per share, with a total value of £9,978.90. Company insiders own 1.38% of the company’s stock.
CVS Group Company Profile
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Further Reading
- Five stocks we like better than CVS Group
- The Most Important Warren Buffett Stock for Investors: His Own
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- What is Put Option Volume?
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- Buy P&G Now, Before It Sets A New All-Time High
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
